Text Education About Cardiovascular Health and HIV (TEACH-HIV)

Part of paid clinical trials in San Francisco, California.

Sponsor
University of California, San Francisco
Study ID
NCT05642858
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
40 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Digital Educational Messaging — BEHAVIORAL
    Education via mobile phone text messages for up to 6 months.

Study Details

The overall objective is to evaluate the efficacy of educational text messages to reduce cardiovascular risk among persons living with HIV (PLWH).

Key Dates

Start date
Mar 12, 2023
Status verified
Jun 2025
Primary completion
Dec 1, 2025
Completion
Jul 1, 2026

Study Design

Enrollment
260 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Intervention Arm
    The intervention arm will receive education about HIV and heart disease risk via mobile phone text messages for up to 6 months. They will receive the text messages 3-5 times per week. The messages will include information about HIV and risk of heart disease and information about how to reduce heart disease risk. The intervention arm will also receive brief monthly surveys via a digital research platform.
  • No Intervention: Control Arm
    The control arm will not receive the educational text messages. They will receive brief monthly surveys via a digital research platform.

Primary Outcome Measure

Proportion of participants with controlled blood pressure [ Time Frame: 6 months ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
University of California San FranciscoSan FranciscoCalifornia94115
Megan Mclaughlin, MD, MPH
Zuckerberg San Francisco General HospitalSan FranciscoCalifornia94110
Megan McLaughlin, MD, MPH

Find similar trials in San Francisco, CA

By condition
By specialty

Related Studies